0001104659-20-094442.txt : 20200813
0001104659-20-094442.hdr.sgml : 20200813
20200813100344
ACCESSION NUMBER: 0001104659-20-094442
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200813
DATE AS OF CHANGE: 20200813
EFFECTIVENESS DATE: 20200813
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management III, LLC
CENTRAL INDEX KEY: 0001645157
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17183
FILM NUMBER: 201097693
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001645157
XXXXXXXX
06-30-2020
06-30-2020
false
Foresite Capital Management III, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-17183
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
08-13-2020
0
8
112465
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
4004
42030
SH
SOLE
42030
0
0
Blueprint Medicines Corporation
COM
09627Y109
19469
249598
SH
SOLE
249598
0
0
Cymabay Therapeutics, Inc.
COM
23257D103
5584
1599958
SH
SOLE
1599958
0
0
Epizyme, Inc.
COM
29428V104
16032
998278
SH
SOLE
998278
0
0
FibroGen, Inc.
COM
31572Q808
1621
40000
SH
SOLE
40000
0
0
Myokardia, Inc.
COM
62857M105
38586
399360
SH
SOLE
399360
0
0
Natera, Inc.
COM
632307104
10409
208768
SH
SOLE
208768
0
0
Oric Pharmaceuticals, Inc.
COM
68622P109
16760
496893
SH
SOLE
496893
0
0